← Back to all trials
Enrolling By Invitation
NCT07307833
Impact of Immunotherapy on Vestibular Function, The Mayo Clinic Arizona Experience
Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 50
Sponsor: Mayo Clinic
Location: Mayo Clinic in Arizona Scottsdale Arizona
Summary
This study evaluates the impact of immunotherapy on balance in patients receiving immunotherapy as part of their standard of care.
Eligibility Criteria
Inclusion Criteria:
* At least 18 years of age at screening
* Patients who will be initiating single agent immunotherapy with pembrolizumab, cemiplimab, nivolumab, atezolizumab, or dual therapy with (Ipilimumab/Nivolumab or Nivolumab/Relatlimab)
Exclusion Criteria:
* Concurrent chemotherapy
Source: ClinicalTrials.gov (NCT07307833). StuddyBuddy aggregates publicly available trial information.
